Add as a preferred source on GoogleNeuroPace Cuts 2026 Revenue Outlook to $91 Million-$92 Million
The company expects RNS System revenue to grow about 15% in 2027, with growth accelerating toward 20% by year-end.
NeuroPace lowered its 2026 revenue outlook to $91 million to $92 million after third-quarter sales fell short of expectations, while projecting faster growth in its RNS System business next year.
Revenue for the third quarter totaled $23.1 million, including $22.9 million from the RNS System. NeuroPace President and CEO Joel Becker said, “Our third quarter results fell short of our expectations.”
The company attributed the shortfall to issues at large accounts, including staffing, physician availability and diagnostic capacity. Sales-force transitions and reduced operating-room access after NeuroPace exited the SEEG distribution business also weighed on results.
NeuroPace expects RNS System revenue to grow about 15% in 2027, with growth accelerating toward 20% as the year ends.
The company submitted its Remote Care materials ahead of schedule and expects to submit an IGE amendment around year-end. A possible approval of the amendment could come by mid-2027.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.